Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

68Ga-DOTATATE Imaging in Neuroendocrine Tumors

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT02174679
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:38.489786+00:00
Published At
2020-07-27T00:00:00+00:00
Record Updated At
2020-07-27
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Carcinoid Cancer", "Neuroendocrine Tumors", "Medullary Thyroid Cancer", "Cancers Expressing Somatostatin Receptors"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2020-07-27"
protocolSection.identificationModule.nctId
"NCT02174679"
protocolSection.identificationModule.officialTitle
"68Ga-DOTATATE Imaging in Neuroendocrine Tumors"
protocolSection.statusModule.overallStatus
"NO_LONGER_AVAILABLE"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Carcinoid Cancer (protocolSection.conditionsModule.conditions)
  • Neuroendocrine Tumors (protocolSection.conditionsModule.conditions)
  • Medullary Thyroid Cancer (protocolSection.conditionsModule.conditions)
  • Cancers Expressing Somatostatin Receptors (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.